1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Zogenix Inc (ZGNX)
  7. Quote


Zogenix Stock Price

0.03 (0.19%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 307,989
Bid Price 14.75
Ask Price 16.60
News -
Day High 15.63


52 Week Range


Day Low 15.19
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Zogenix Inc ZGNX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.03 0.19% 15.44 20:00:01
Open Price Low Price High Price Close Price Prev Close
15.40 15.19 15.63 15.44 15.41
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,774 307,989 $ 15.41 $ 4,746,648 - 13.01 - 23.69
Last Trade Time Type Quantity Stock Price Currency
19:52:24 40 $ 15.65 USD


Draw Mode:

Zogenix Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 863.06M 55.90M 55.65M $ 13.64M $ - -3.86 -3.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 43.64k 2.00%

more financials information »

Zogenix News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ZGNX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week15.6916.0815.0715.54374,669-0.25-1.59%
1 Month16.03516.27515.0215.61442,109-0.595-3.71%
3 Months16.4616.9813.0115.00620,669-1.02-6.2%
6 Months18.7419.7013.0116.79783,302-3.30-17.61%
1 Year20.3623.6913.0118.74812,678-4.92-24.17%
3 Years41.6757.2213.0128.60789,276-26.23-62.95%
5 Years8.7562.757.5030.62714,9326.6976.46%

Zogenix Description

Zogenix Inc is engaged in developing and commercializing therapeutic solutions for people living with serious and life-threatening rare CNS disorders and medical conditions. Its product candidate includes ZX008, low-dose fenfluramine for the treatment of Dravet syndrome, LGS, and potentially other rare and catastrophic epilepsy disorders.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.